ETPrime

    Share Price

    Stock not traded on NSE/BSE

    share price insights

    We don’t have any Insights for this stock currently . We suggest you to explore other sections for more!

    Key Metrics

    PE Ratio
    (x)    		-
    EPS - TTM
    (₹)    		-
    MCap
    (₹ Cr.)    		-
    Sectoral MCap Rank
    		-
    PB Ratio
    (x)    		-
    Div Yield
    (%)    		-
    Face Value
    (₹)    		-
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    		-
    VWAP
    (₹)    		-
    52W H/L
    (₹)
    - / -

    Share Price Returns

    1 DayN.A.
    1 WeekN.A.
    1 MonthN.A.
    3 MonthsN.A.
    1 YearN.A.
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether belongs to analysts' top-rated companies list?

    View Stock Screeners

    News & Analysis

    View all Share News & Announcements

    Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Financials

    • Quarterly | AnnualDec 2018Sep 2018Jun 2018Mar 2018Dec 2017
      Total Income0.000.000.000.010.01
      Total Income Growth (%)---100.00-42.5921.35
      Total Expenses0.010.010.000.010.01
      Total Expenses Growth (%)22.0021.95-71.3381.01-31.90
      EBIT-0.01-0.010.00-0.010.00
      EBIT Growth (%)----379.31-
      Profit after Tax (PAT)-0.01-0.010.00-0.010.00
      PAT Growth (%)----379.31-
      EBIT Margin (%)----130.6526.85
      Net Profit Margin (%)----130.6526.85
      Basic EPS (₹)-0.01-0.01-0.01-0.020.01
      Quarterly | Annual FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
      Total Revenue0.040.040.050.030.02
      Total Revenue Growth (%)-4.35-22.1463.3473.0678.92
      Total Expenses0.080.070.080.060.04
      Total Expenses Growth (%)1.71-6.0343.0342.6923.75
      Profit after Tax (PAT)-0.04-0.04-0.03-0.03-0.02
      PAT Growth (%)-----
      Operating Profit Margin (%)0.000.000.000.000.00
      Net Profit Margin (%)0.000.000.000.000.00
      Basic EPS (₹)-0.10-0.09-0.08-0.06-0.05

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
      Total Assets2.032.052.102.112.14
      Total Assets Growth (%)-0.98-2.38-0.47-1.40-0.93
      Total Liabilities0.030.010.020.000.01
      Total Liabilities Growth (%)200.00-50.00--100.000.00
      Total Equity2.002.042.082.112.13
      Total Equity Growth (%)-1.96-1.92-1.42-0.94-1.39
      Current Ratio (x)70.12170.6390.71680.98407.20
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities-----

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Annual FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
      Net Cash flow from Operating Activities--0.000.310.13
      Net Cash used in Investing Activities--0.000.000.00
      Net Cash flow from Financing Activities--0.000.000.00
      Net Cash Flow--0.000.310.13
      Closing Cash & Cash Equivalent--0.530.540.23
      Closing Cash & Cash Equivalent Growth (%)0.000.00-0.80131.40116.93
      Total Debt/ CFO (x)--0.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
      Return on Equity (%)-2.00-1.82-1.51-1.23-1.02
      Return on Capital Employed (%)-2.00-1.82-1.51-1.23-1.02
      Return on Assets (%)-1.97-1.81-1.49-1.23-1.02
      Interest Coverage Ratio (x)0.000.000.000.000.00
      Asset Turnover Ratio (x)--0.000.000.00
      Price to Earnings (x)-6.81-7.67-15.41-23.04-60.61
      Price to Book (x)0.140.140.230.280.62
      EV/EBITDA (x)3.815.311.63-2.30-49.91
      EBITDA Margin (%)0.000.000.000.000.00

      No reported Financial Ratios are available.

    Financial Insights

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Technicals

        • Stock doesn't have any Buy/Sell Signals.

        • Price Analysis Data details are not available.

        • Pivot Levels

          R1R2R3PIVOTS1S2S3
          Classic-------

          Average True Range

          5 DAYS14 DAYS28 DAYS
          ATR---

        Peer Comparison

          • CHART
          • TABLE

          • Choose from Peers

              Choose from Stocks

              • 1D
              • 1W
              • 1M
              • 3M
              • 6M
              • 1Y
              • 5Y
              Loading...

            • Ratio Performance

              NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
              Vardhaman Lab-9.030.11-2.00-2.00-1.976.680.000.00-0.1070.120.000.00
              Unjha Form115.553.5612.9816.918.94-0.873.832.930.912.370.000.00
              Colinz Labs22.521.145.246.854.20-1.5010.137.601.974.170.07-0.44
              Ortin Labs-11.670.4418.8534.775.67-63.9312.105.382.731.110.580.00
              Kamron Labs.-183.90-7.040.00-74.83-175.09-35.060.000.00-0.214.46-1.00-6.58
              Add More
              Annual Ratios (%)

              Choose from Peers

              • Vivanza Biosciences
              • Brawn Biotech
              • Shyama Infosys
              • Avon Lifesciences
              • Advik Labs

              Choose from Stocks

                See All Parameters

              Peers Insights

                Do you find these insights useful?

                • hate it

                • meh

                • love it

                Shareholding Pattern

                Shareholding details are not available.

                MF Ownership

                MF Ownership details are not available.

                Top Searches:
                News Quarterly Results Dividend Q1 Results Q2 Results Q3 Results Q4 Results

                Corporate Actions

                • Meeting DateAnnounced onPurposeDetails
                  Feb 14, 2019Feb 08, 2019Board MeetingQuarterly Results
                  Nov 14, 2018Nov 06, 2018Board MeetingQuarterly Results
                  Sep 29, 2018Aug 14, 2018AGM-
                  Aug 14, 2018Aug 06, 2018Board MeetingQuarterly Results
                  May 30, 2018May 23, 2018Board MeetingAudited Results
                • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
                  Final -0.0-Jun 23, 1999

                • No other corporate actions details are available.

                About

                Vardhaman Laboratories Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs .21 Crore) operating in Pharmaceuticals sector. Vardhaman Laboratories Ltd. key Products/Revenue Segments include for the year ending 31-Mar-2018. Show More

                • Executives

                • Auditors

                • DS

                  Dharamchand Shah

                  Chairman
                  DN

                  Dayanand Naik

                  Ind. Non-Executive Director
                  RP

                  Rajendra Petare

                  Ind. Non-Executive Director
                  UP

                  Umesh Patil

                  Ind. Non-Executive Director
                  Show More
                • Agrawal Naredi & Co.

                Industry

                Pharma - Indian

                Key Indices Listed on

                -

                Address

                1393, Peth Bhag,High School Road,Sangli, Maharashtra - 416416

                Contact

                vardhaman.lab@gmail.com

                More Details

                DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

                DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

                By using this site, you agree to the Terms of Service and Privacy Policy.

                Business News›Markets›Stocks›Stock Price Quotes› Share Price
                The Economic Times
                BrowseCompanies: